Prognostic biomarker RASSF1 in head and neck squamous cell carcinoma

Asian J Surg. 2023 Oct;46(10):4425-4427. doi: 10.1016/j.asjsur.2023.04.086. Epub 2023 May 3.

¹ Department of Otolaryngology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Electronic address: sysmah@163.com.
² Department of Otolaryngology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Electronic address: menglh7@163.com.
³ Department of Otolaryngology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Electronic address: zhangbingwen0101@163.com.
⁴ Department of Otolaryngology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Electronic address: qijianwei0202@163.com.

No abstract available

Keywords: Clinical features; HNSCC; Prognosis; RASSF1.

Publication types